SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-021415
Filing Date
2023-08-01
Accepted
2023-08-01 16:23:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A urgn20230801_defa14a.htm DEFA14A 12282
2 proxycardfinal08012023pg1of2.jpg GRAPHIC 101464
3 proxycardfinalpg2of2.jpg GRAPHIC 86096
  Complete submission text file 0001437749-23-021415.txt   260919
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38079 | Film No.: 231132052
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences